NCT07569549

Brief Summary

The goal of this clinical trial is to learn if the surgical method with total joint arthroplasty, (TOUCH joint prosthesis), is as good as or better than the traditional surgical method, trapezectomy, to treat thumb base joint osteoarthritis. The main questions it aims to answer are: Does surgery with total joint arthroplasty provide better power grip and pinch grip strength compared to traditional surgery? What is the long-term risk of complications for both methods? Which method is more cost-effective for the healthcare system? Researchers will compare total joint arthroplasty (TOUCH) to trapezectomy (a procedure where a bone in the thumb base is removed) to see which method provides the best results for the patient. Participants will: Be randomized to undergo either an operation with total joint arthroplasty or a trapezectomy. Undergo an initial evaluation and a health economic cost analysis after one year. Attend follow-up checkups at 2, 5, and 10 years post-surgery to evaluate long-term function and the durability of the prosthesis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
144mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 6, 2026

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2030

Expected
7.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2038

Last Updated

May 6, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

April 27, 2026

Last Update Submit

May 4, 2026

Conditions

Keywords

Thumb base arthroplastyCMC jointprosthesishand surgeryFirst Carpometacarpal JointTrapeziometacarpal JointRhizarthrosisThumb OsteoarthritisDual Mobility ProsthesisTotal Joint ReplacementTotal Joint ArthroplastyLigament ReconstructionSurgical ReconstructionRandomized Controlled Trial (RCT)Prospective StudiesComparative StudyProspective StudyCost-Effectiveness AnalysisCost-Benefit AnalysisHealth EconomicsPatient Reported Outcome Measures (PROMs)Quality of Life (QoL)Health-Related Quality of Life (HRQoL)Return to WorkGrip StrengthPinch StrengthQuickDASHEQ-5DMichigan Hand Outcomes Questionnaire (MHQTrapeziectomy

Outcome Measures

Primary Outcomes (1)

  • Hand grip strength

    Hand grip strength (JAMAR dynamometer) at 12 months post operatively

    Measured at 12 months postoperatively

Secondary Outcomes (13)

  • Key-pinch grip strength

    Measured at 6 weeks, 12 weeks, and 12 months postoperatively

  • Pinch grip strength

    Measured at 6 weeks, 12 weeks and 12 months postoperatively

  • Postoperative Pain Intensity on a Numeric Rating Scale (NRS)

    Measured at 6 weeks, 12 weeks and 12 months postoperatively

  • Range of movement

    Measured at 6 weeks, 12 weeks and 12 months postoperatively

  • Metacarpophalangeal (MCP)-joint hyperextension

    Measured at 6 weeks, 12 weeks and 12 months postoperatively

  • +8 more secondary outcomes

Study Arms (2)

Arm 1 -Dual Mobility Prosthesis (TOUCH)

EXPERIMENTAL

TOUCH Total Joint Arthroplasty (n=42). Implantation of TOUCH trapeziometacarpal prosthesis (Kerimedical). Soft bandage for 3 weeks postoperatively, followed by rehabilitation per national guidelines.

Device: Implantation of trapeziometacarpal prosthesis

Arm 2 - Trapeziectomy and Capsular Reconstruction

ACTIVE COMPARATOR

Trapezectomy with capsuloplasty (n=42). Excision of trapezium with dorsal capsule flap capsuloplasty. Cast immobilization for 3 weeks postoperatively, followed by rehabilitation per national guidelines.

Procedure: Trapeziectomy with Capsuloplasty

Interventions

Surgical implantation of the TOUCH trapeziometacarpal total joint prosthesis (Kerimedical). The prosthesis consists of an uncemented stainless steel stem inserted into the first metacarpal and a dual cup mobility system with a polyethylene ball articulating against a metal cup fixed in the trapezium. The stem is available in straight or 15-degree angled neck configurations. Postoperative management consists of a stable soft dressing for 3 weeks to allow early controlled mobilization, followed by a standardized hand therapy rehabilitation protocol.

Also known as: TOUCH Dual-Mobility Prosthesis
Arm 1 -Dual Mobility Prosthesis (TOUCH)

Surgical excision of the trapezium bone (trapeziectomy) followed by capsuloplasty using a distally based dorsal capsular flap, without tendon interposition. The capsular flap is sutured to stabilize the base of the first metacarpal. No implant or tendon graft is used. Postoperatively, a cast immobilizing the thumb in functional position is applied for 3 weeks, followed by a standardized hand therapy rehabilitation protocol.

Arm 2 - Trapeziectomy and Capsular Reconstruction

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CMC-joint osteoarthritis grade 1-3 (Eaton-Littler classification)
  • Rest pain or pain reducing hand function with indication for surgery
  • Insufficient relief from non-operative treatment for ≥3 months (orthosis, OTC analgesics, cortisone injection)
  • Eligible for both prosthesis and trapezectomy per including surgeon
  • Non-smoker or complete smoking cessation ≥6 weeks prior to surgery

You may not qualify if:

  • Previous surgery to thumb base or STT-joint
  • Ongoing chronic pain condition
  • Dementia or cognitive impairment
  • Trapezium height \<7 mm on plain radiograph
  • Active smoker
  • Osteoarthritis grade 4 (Eaton-Littler)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Örebro university hospital

Örebro, Sweden

Location

Department of Handsurgery, Uppsala University Hospital

Uppsala, Sweden

Location

Related Publications (10)

  • Werle S, Goldhahn J, Drerup S, Simmen BR, Sprott H, Herren DB. Age- and gender-specific normative data of grip and pinch strength in a healthy adult Swiss population. J Hand Surg Eur Vol. 2009 Feb;34(1):76-84. doi: 10.1177/1753193408096763. Epub 2009 Jan 7.

    PMID: 19129352BACKGROUND
  • Kim JK, Park MG, Shin SJ. What is the minimum clinically important difference in grip strength? Clin Orthop Relat Res. 2014 Aug;472(8):2536-41. doi: 10.1007/s11999-014-3666-y. Epub 2014 May 10.

    PMID: 24817380BACKGROUND
  • Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW. Estimating minimal clinically important differences of upper-extremity measures early after stroke. Arch Phys Med Rehabil. 2008 Sep;89(9):1693-700. doi: 10.1016/j.apmr.2008.02.022.

    PMID: 18760153BACKGROUND
  • Kierkegaard M, Petitclerc E, Hebert LJ, Mathieu J, Gagnon C. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1. J Rehabil Med. 2018 Feb 28;50(3):269-277. doi: 10.2340/16501977-2304.

    PMID: 29260836BACKGROUND
  • Draak TH, Pruppers MH, van Nes SI, Vanhoutte EK, Bakkers M, Gorson KC, Van der Pol WL, Lewis RA, Notermans NC, Nobile-Orazio E, Leger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, van den Berg LH, van Doorn PA, Cornblath DR, Hahn AF, Faber CG, Merkies IS; PeriNomS study group. Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar. J Peripher Nerv Syst. 2015 Sep;20(3):269-76. doi: 10.1111/jns.12126.

    PMID: 26115516BACKGROUND
  • Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019 Jan;31(1):75-78. doi: 10.1589/jpts.31.75. Epub 2019 Jan 10.

    PMID: 30774209BACKGROUND
  • Herren DB, Marks M, Neumeister S, Schindele S. Low complication rate and high implant survival at 2 years after Touch(R) trapeziometacarpal joint arthroplasty. J Hand Surg Eur Vol. 2023 Oct;48(9):877-883. doi: 10.1177/17531934231179581. Epub 2023 Jun 13.

    PMID: 37310049BACKGROUND
  • Kriegs-Au G, Petje G, Fojtl E, Ganger R, Zachs I. Ligament reconstruction with or without tendon interposition to treat primary thumb carpometacarpal osteoarthritis. A prospective randomized study. J Bone Joint Surg Am. 2004 Feb;86(2):209-18. doi: 10.2106/00004623-200402000-00001.

    PMID: 14960663BACKGROUND
  • Guzzini M, Arioli L, Annibaldi A, Pecchia S, Latini F, Ferretti A. Interposition Arthroplasty versus Dual Cup Mobility Prosthesis in Treatment of Trapeziometacarpal Joint Osteoarthritis: A Prospective Randomized Study. Hand (N Y). 2024 Nov;19(8):1260-1268. doi: 10.1177/15589447231185584. Epub 2023 Jul 23.

    PMID: 37482747BACKGROUND
  • Newton A, Talwalkar S. Arthroplasty in thumb trapeziometacarpal (CMC joint) osteoarthritis: An alternative to excision arthroplasty. J Orthop. 2022 Nov 26;35:134-139. doi: 10.1016/j.jor.2022.11.011. eCollection 2023 Jan.

    PMID: 36471695BACKGROUND

MeSH Terms

Conditions

Capillary Malformations, Congenital, 1

Study Officials

  • Nils Hailer, MD, PhD. Professor

    Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden

    STUDY DIRECTOR
  • Sara Edsfeldt, MD, PhD, senior attending

    Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden

    PRINCIPAL INVESTIGATOR
  • Sara Edsfeldt, MD, PhD, senior attending

    Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden

    STUDY CHAIR

Central Study Contacts

Eva Nordin, Clinical research nurse

CONTACT

Elias Gardell, MD, attending hand surgeon

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 6, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

May 1, 2030

Study Completion (Estimated)

March 1, 2038

Last Updated

May 6, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that underlie the results reported in this article (text, tables, figures, and appendices) will be made available to researchers who provide a methodologically sound proposal. Data will be available beginning 6 months and ending 5 years after publication. Requests should be directed to Central contact person. To gain access, data requestors will need to sign a data access agreement and provide proof of approval from the Swedish Ethical Review Authority.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Beginning 6 months and ending 5 years after publication
Access Criteria
Access will be granted to qualified academic researchers who provide a methodologically sound scientific proposal. The request must be consistent with the informed consent provided by the participants. Access requires a formal Data Sharing Agreement (DSA) and a valid ethical approval from the Swedish Ethical Review Authority (Etikprövningsmyndigheten). The requesting party must also demonstrate that they have the necessary infrastructure to handle sensitive data according to GDPR

Locations